Current developments of gene therapy in human diseases

被引:2
作者
Liu, Fanfei [1 ]
Li, Ruiting [2 ]
Zhu, Zilin [3 ]
Yang, Yang [1 ,2 ]
Lu, Fang [1 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Ophthalmol, Chengdu, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China
[3] Sichuan Univ, Coll Life Sci, Chengdu, Sichuan, Peoples R China
来源
MEDCOMM | 2024年 / 5卷 / 09期
基金
中国国家自然科学基金;
关键词
AAV; clinical trials; CRISPR-Cas; gene therapy; human diseases; DUCHENNE MUSCULAR-DYSTROPHY; MACULAR DEGENERATION; OPEN-LABEL; PARKINSONS-DISEASE; IN-VIVO; VORETIGENE NEPARVOVEC; AUREUS CRISPR-CAS9; IMMUNE-RESPONSES; RECOMBINANT AAV; HEART-FAILURE;
D O I
10.1002/mco2.645
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Gene therapy has witnessed substantial advancements in recent years, becoming a constructive tactic for treating various human diseases. This review presents a comprehensive overview of these developments, with a focus on their diverse applications in different disease contexts. It explores the evolution of gene delivery systems, encompassing viral (like adeno-associated virus; AAV) and nonviral approaches, and evaluates their inherent strengths and limitations. Moreover, the review delves into the progress made in targeting specific tissues and cell types, spanning the eye, liver, muscles, and central nervous system, among others, using these gene technologies. This targeted approach is crucial in addressing a broad spectrum of genetic disorders, such as inherited lysosomal storage diseases, neurodegenerative disorders, and cardiovascular diseases. Recent clinical trials and successful outcomes in gene therapy, particularly those involving AAV and the clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated proteins, are highlighted, illuminating the transformative potentials of this approach in disease treatment. The review summarizes the current status of gene therapy, its prospects, and its capacity to significantly ameliorate patient outcomes and quality of life. By offering comprehensive analysis, this review provides invaluable insights for researchers, clinicians, and stakeholders, enriching the ongoing discourse on the trajectory of disease treatment. Gene therapy has seen remarkable advancements in recent decades, demonstrating its immense potential in treating a wide range of genetic and acquired diseases. Several AAV gene therapy products have been introduced to the market, addressing various conditions. This review explores the clinical applications of AAV in major human diseases, including ocular diseases, neuromuscular diseases, hematological diseases, neurological diseases, cardiovascular diseases, and lysosomal storage diseases. image
引用
收藏
页数:30
相关论文
共 215 条
  • [61] AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges
    Gardner, Matthew R.
    Kattenhorn, Lisa M.
    Kondur, Hema R.
    von Schaewen, Markus
    Dorfman, Tatyana
    Chiang, Jessica J.
    Haworth, Kevin G.
    Decker, Julie M.
    Alpert, Michael D.
    Bailey, Charles C.
    Neale, Ernest S., Jr.
    Fellinger, Christoph H.
    Joshi, Vinita R.
    Fuchs, Sebastian P.
    Martinez-Navio, Jose M.
    Quinlan, Brian D.
    Yao, Annie Y.
    Mouquet, Hugo
    Gorman, Jason
    Zhang, Baoshan
    Poignard, Pascal
    Nussenzweig, Michel C.
    Burton, Dennis R.
    Kwong, Peter D.
    Piatak, Michael, Jr.
    Lifson, Jeffrey D.
    Gao, Guangping
    Desrosiers, Ronald C.
    Evans, David T.
    Hahn, Beatrice H.
    Ploss, Alexander
    Cannon, Paula M.
    Seaman, Michael S.
    Farzan, Michael
    [J]. NATURE, 2015, 519 (7541) : 87 - U173
  • [62] Multiyear Factor VIII Expression after AAV Gene Transfer for Hemophilia A
    George, Lindsey A.
    Monahan, Paul E.
    Eyster, M. Elaine
    Sullivan, Spencer K.
    Ragni, Margaret, V
    Croteau, Stacy E.
    Rasko, John E. J.
    Recht, Michael
    Samelson-Jones, Benjamin J.
    MacDougall, Amy
    Jaworski, Kristen
    Noble, Robert
    Curran, Marla
    Kuranda, Klaudia
    Mingozzi, Federico
    Chang, Tiffany
    Reape, Kathleen Z.
    Anguela, Xavier M.
    High, Katherine A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (21) : 1961 - 1973
  • [63] Ocular Gene Therapy: A Literature Review with Special Focus on Immune and Inflammatory Responses
    Ghoraba, Hashem H.
    Akhavanrezayat, Amir
    Karaca, Irmak
    Yavari, Negin
    Lajevardi, Sherin
    Hwang, Jaclyn
    Regenold, Jonathan
    Matsumiya, Wataru
    Pham, Brandon
    Zaidi, Moosa
    Mobasserian, Azadeh
    DongChau, Anthony Toan
    Or, Christopher
    Yasar, Cigdem
    Mishra, Kapil
    Do, Diana
    Nguyen, Quan Dong
    [J]. CLINICAL OPHTHALMOLOGY, 2022, 16 : 1753 - 1771
  • [64] Viral Vector Systems for Gene Therapy: A Comprehensive Literature Review of Progress and Biosafety Challenges
    Ghosh, Sumit
    Brown, Alex M.
    Jenkins, Chris
    Campbell, Katie
    [J]. APPLIED BIOSAFETY, 2020, 25 (01) : 7 - 18
  • [65] Genome-editing applications of CRISPR-Cas9 to promote in vitro studies of Alzheimer's disease
    Giau, Vo Van
    Lee, Hyon
    Shim, Kyu Hwan
    Bagyinszky, Eva
    An, Seong Soo A.
    [J]. CLINICAL INTERVENTIONS IN AGING, 2018, 13 : 221 - 233
  • [66] Sorsby Fundus Dystrophy: Novel Mutations, Novel Phenotypic Characteristics, and Treatment Outcome
    Gliem, Martin
    Mueller, Philipp L.
    Mangold, Elisabeth
    Holz, Frank G.
    Bolz, Hanno J.
    Stoehr, Heidi
    Weber, Bernhard H. F.
    Issa, Peter Charbel
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (04) : 2664 - 2676
  • [67] Common Pathogenic Mechanisms in Centronuclear and Myotubular Myopathies and Latest Treatment Advances
    Gomez-Oca, Raquel
    Cowling, Belinda S.
    Laporte, Jocelyn
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (21)
  • [68] HemophiliaB: molecular pathogenesis and mutation analysis
    Goodeve, A. C.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 (07) : 1184 - 1195
  • [69] Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial
    Greenberg, Barry
    Butler, Javed
    Felker, G. Michael
    Ponikowski, Piotr
    Voors, Adriaan A.
    Desai, Akshay S.
    Barnard, Denise
    Bouchard, Alain
    Jaski, Brian
    Lyon, Alexander R.
    Pogoda, Janice M.
    Rudy, Jeffrey J.
    Zsebo, Krisztina M.
    [J]. LANCET, 2016, 387 (10024) : 1178 - 1186
  • [70] Preclinical Evaluation of ADVM-022, a Novel Gene Therapy Approach to Treating Wet Age-Related Macular Degeneration
    Grishanin, Ruslan
    Vuillemenot, Brian
    Sharma, Pallavi
    Keravala, Annahita
    Greengard, Judith
    Gelfman, Claire
    Blumenkrantz, Mark
    Lawrence, Matthew
    Hu, Wenzheng
    Kiss, Szilard
    Gasmi, Mehdi
    [J]. MOLECULAR THERAPY, 2019, 27 (01) : 118 - 129